Bengt Andersson

Title: The Innovations of Bengt Andersson

Introduction

Bengt Andersson is a notable inventor based in Gothenburg, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the modulation of dopamine neurotransmission. With a total of 2 patents, his work has implications for the treatment of various central nervous system disorders.

Latest Patents

Andersson's latest patents focus on new 3-substituted 4-(phenyl-N-alkyl)-piperazine and 4-(phenyl-N-alkyl)-piperidine compounds. These compounds are designed to modulate dopamine neurotransmission and include various chemical structures that enhance their efficacy. The patents disclose pharmaceutical compositions comprising these compounds and methods for their use in treating disorders of the central nervous system.

Career Highlights

Throughout his career, Bengt Andersson has worked with prominent companies in the pharmaceutical industry. He has been associated with Teva Pharmaceuticals International GmbH and Neurosearch Sweden AB. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Andersson has collaborated with notable colleagues such as Clas Sonesson and Susanna Waters. These partnerships have likely enriched his research and development efforts in the pharmaceutical field.

Conclusion

Bengt Andersson's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His work continues to influence the development of treatments for central nervous system disorders.